In the Media Tag: Dr. Wei Li

Memphis scientists instrumental in new, landmark COVID drug

In the Media Icon

The next possible landmark COVID drug is so rich in Memphis DNA that if approved by the FDA, patent royalty checks will immediately flow to town, a legacy of the defunct GTx pharmaceutical company and scientists at the University of Tennessee Health Science Center who created the structure. Sabizabulin was originally created as an anti-cancer… Read More